Accolade (ACCD) Stock Forecast & Price Target

ACCD price $7.02 0.00 0.00%

Ticker
ACCD
Price
$7.02
Change
0.00 0.00%
Market cap ?
$575.59M
P/E ?
-5.28
Forward P/E ?
19.50
Dividend yield ?
0.00%
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Stocklytics score
57
Value
55
Quality
31
Growth
86

Stocklytics score rationale: value 55, quality 31, growth 86.

Financials

2018201920202021202220232024
7682800094811000132507000170358000310021000363142000414292000

Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal…

Forecast

Consensus Hold from 20 analysts. Average price target $13.97, +99.0% versus the current price. Low $5.00. High $52.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Accolade (ACCD) Stock Forecast & Price Target

ACCD$7.020.00 0.00%

$575.59M

Market Cap

-5.28

P/E

19.50

Forward P/E

57

Score

Price History

Financial Summary

Accolade, Inc. (ACCD) trades at $7.02, with a market cap of $575.59M and a trailing P/E of -5.28. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2018201920202021202220232024
7682800094811000132507000170358000310021000363142000414292000

About

Accolade, Inc., along with its subsidiaries, specializes in providing innovative, technology-driven solutions across the United States. These solutions are designed to empower individuals to better understand, navigate, and ultimately leverage both the complex healthcare system and their available workplace benefits. At the core of its offering is a robust cloud-based platform that delivers comprehensive, multimodal…